Trials / Unknown
UnknownNCT03474250
Trans-aortic Valve Replacement and Renal Infarction
Trans-catheter Aortic Valve Replacement and Renal Infarction Among Patients With Severe Aortic Stenosis
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (estimated)
- Sponsor
- Sheba Medical Center · Other Government
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Kidney Magnetic Resonance assessment before and after undergoing transcatheter aortic valve replacement
Detailed description
Each patient will undergo Magnetic Resonance assessment of the kidneys before the TAVR. on the third to 7th day after the ATVR, a second MRI to the kidneys will be performed. we will assess the changes and new lesions between both MRI tests and will perform a qualitative and quantitative measurement.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Magnetic Resonance test for kidney | Magnetic Resonance test for kidney |
Timeline
- Start date
- 2018-04-01
- Primary completion
- 2018-12-31
- Completion
- 2018-12-31
- First posted
- 2018-03-22
- Last updated
- 2018-05-01
Locations
1 site across 1 country: Israel
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03474250. Inclusion in this directory is not an endorsement.